These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1351303)
1. Flesinoxan shows antidepressant activity in a DRL 72-s screen. van Hest A; van Drimmelen M; Olivier B Psychopharmacology (Berl); 1992; 107(4):474-9. PubMed ID: 1351303 [TBL] [Abstract][Full Text] [Related]
2. Can the DRL 72s schedule selectively reveal antidepressant drug activity? Jackson A; Koek W; Colpaert FC Psychopharmacology (Berl); 1995 Jan; 117(2):154-61. PubMed ID: 7753961 [TBL] [Abstract][Full Text] [Related]
4. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule. O'Donnell JM; Marek GJ; Seiden LS Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376 [TBL] [Abstract][Full Text] [Related]
5. Effects of salbutamol upon performance on an operant screen for antidepressants. Dunn RT; Richards JB; Seiden LS Psychopharmacology (Berl); 1993; 113(1):1-10. PubMed ID: 7862813 [TBL] [Abstract][Full Text] [Related]
6. Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low rate 72-S (DRL 72-S) schedule of reinforcement. Marek GJ; Heffner TG; Richards JB; Shaughnessy RA; Li AA; Seiden LS Pharmacol Biochem Behav; 1993 Aug; 45(4):987-90. PubMed ID: 8415842 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule. Chiang FK; Cheng RK; Liao RM Pharmacol Biochem Behav; 2015 Mar; 130():67-76. PubMed ID: 25584855 [TBL] [Abstract][Full Text] [Related]
8. The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition. Paterson NE; Balci F; Campbell U; Olivier BE; Hanania T J Psychopharmacol; 2011 Oct; 25(10):1357-64. PubMed ID: 20305042 [TBL] [Abstract][Full Text] [Related]
9. Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Seiden LS; Dahms JL; Shaughnessy RA Psychopharmacology (Berl); 1985; 86(1-2):55-60. PubMed ID: 3161116 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior. Marek GJ; Seiden LS Psychopharmacology (Berl); 1988; 96(2):153-60. PubMed ID: 3148140 [TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine. Li AA; Marek GJ; Hand TH; Seiden LS Eur J Pharmacol; 1990 Feb; 177(3):137-44. PubMed ID: 2311675 [TBL] [Abstract][Full Text] [Related]
12. The effects of chlordiazepoxide and d-amphetamine during a three-component multiple schedule. Romanowich P; Lamb RJ J Exp Anal Behav; 2013 Jul; 100(1):88-101. PubMed ID: 23633164 [TBL] [Abstract][Full Text] [Related]
13. Schedule-dependent effects of haloperidol and amphetamine: multiple-schedule task shows within-subject effects. Caul WF; Brindle NA Pharmacol Biochem Behav; 2001 Jan; 68(1):53-63. PubMed ID: 11274708 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Mobini S; Chiang TJ; Ho MY; Bradshaw CM; Szabadi E Psychopharmacology (Berl); 2000 Sep; 152(1):47-54. PubMed ID: 11041315 [TBL] [Abstract][Full Text] [Related]
15. Effects of corticotropin releasing factor, desipramine and haloperidol on a DRL schedule of reinforcement. Britton KT; Koob GF Pharmacol Biochem Behav; 1989 Apr; 32(4):967-70. PubMed ID: 2798545 [TBL] [Abstract][Full Text] [Related]